How the classification of von Willebrand Disease can guide therapy

Michael Laffan

doi:10.17225/jhp00072

Abstract

Abstract

In a recent editorial published in Haemophilia, Millar asks ‘Why and how do we classify von Willebrand disease?’ [1]. This may seem like a philosophical question, but two case reports in this edition of The Journal of Haemophilia Practice illustrate good practical answers to both parts of the question.

Article

View Full Article

References

1. Millar C. Why and how do we classify von Willebrand disease? Haemophilia 2015; 21(4): 407-10. doi: 10.1111/hae.12725.
2. Laffan MA, Lester W, O’Donnell JS, Will A, Tait RC, Goodeve A, Millar CM, Keeling DM. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014; 167(4): 453-65. doi: 10.1111/bjh.13064.
3. Rashid S, Bignell P, Keeling D, Curry N. Management of an uncommon form of type 2M VWD: a single centre experience. J Haem Pract 2016; 3(1). doi: 10.17225/jhp00065
4. Fosbury E, Blumberg R, Liesner R, Sibson K. Lessons from a neonate with unusual bleeding. J Haem Pract 2016; 3(1). doi: 10.17225/jhp00064

PDF Download

Download PDF

Open in full-page viewer

Authors

Michael Laffan

m.laffan@imperial.ac.uk

Professor and consultant, Centre for Haematology, Hammersmith Hospital, Imperial College London, London, UK